Publication

A glimpse into the future of model-informed drug discovery and development

Explore the future of Model-Informed Drug Development (MIDD), including advances in pharmacometrics, PBPK, QSP, precision…

Certara2026 年 8 月 28 日

Publication

Refinement of Operating Characteristics for Model-Based TGI Metrics Decision Support to Ungate a Pivotal Trial in Oncology

Explore how model-based tumor growth inhibition metrics can support earlier Go/No-Go decisions and pivotal trial…

Certara2026 年 8 月 28 日

Webinar

The Road to First-in-Human: Model-Informed Decisions from Discovery to First Dose

Danielle Pillsbury2026 年 8 月 28 日

Case Study

De-Risking Phase 3 Rheumatoid Arthritis Trials with Model-Based Meta-Analysis (MBMA)

Learn how Model-based meta-analysis (MBMA) helped optimize Phase 3 trial design, dose selection, and development…

Danielle Pillsbury2026 年 8 月 28 日

Fact Sheet

Model-Based Meta-Analysis (MBMA): Real-World Examples

See real-world examples of how model-based meta-analysis (MBMA) uses existing clinical evidence to predict trial…

Certara2026 年 8 月 24 日

Webinar

How to Choose Your First-in-Human Dose Approach

Certara2026 年 8 月 17 日

Blog

MBMA data curation: How AI and expert meta-analysts get it right, fast

In MBMA, the data layer is the real bottleneck. See how AI and expert meta-analysts…

Matt Zierhut, PhD MBA2026 年 8 月 14 日

Blog

A model-informed approach to radioligand therapy dosing under Project Optimus

Explore how targeted radionuclide therapy dosing uses QSP, biologically effective dose (BED), and exposure-response modeling…

Hunter Stephens, PhD2026 年 8 月 13 日

On-Demand Webinar

Investor panel: What it takes to build a fundable biotech – with Life Science Nation

Investors, founders, and drug development strategists on what makes an early-stage biotech investable beyond the…

Certara2026 年 8 月 6 日

Publication

Advances and Challenges in Model-Informed Precision Dosing of Antimicrobials for Pediatric Patients

Explore advances in model-informed precision dosing (MIPD) for pediatric antimicrobial therapy, including population PK modeling,…

Certara2026 年 7 月 29 日

Certara 服务

A glimpse into the future of model-informed drug discovery and development

Refinement of Operating Characteristics for Model-Based TGI Metrics Decision Support to Ungate a Pivotal Trial in Oncology

The Road to First-in-Human: Model-Informed Decisions from Discovery to First Dose

De-Risking Phase 3 Rheumatoid Arthritis Trials with Model-Based Meta-Analysis (MBMA)

Model-Based Meta-Analysis (MBMA): Real-World Examples

How to Choose Your First-in-Human Dose Approach

MBMA data curation: How AI and expert meta-analysts get it right, fast

A model-informed approach to radioligand therapy dosing under Project Optimus

Investor panel: What it takes to build a fundable biotech – with Life Science Nation

Advances and Challenges in Model-Informed Precision Dosing of Antimicrobials for Pediatric Patients

订阅时事通讯

快捷链接

解决方案

联系我们